Cindy Elkins was Executive Vice President and Chief Information Officer at Juno Therapeutics, one of the pioneers in CAR T blood cancer technology. Following two acquisitions, Cindy served as the Global Head CAR T Patient Experience at Bristol-Myers Squibb (BMS) where her team connected patients with their personalized therapy through world class  service and technology.

Prior to Juno, Cindy was the VP, Pharma Informatics at Genentech-Roche responsible for all technology products/services across the Americas. In 2016, Genentech was ranked #3 in Computerworld’s “100 Best Places to Work in IT”.  Before Genentech, Cindy was the VP and GM of Supplier Solutions at Ariba where she created the largest transacting business to business supplier community in the world.

Her daughter received SAINT TMS in early 2021, as a senior in high school, and benefited greatly from the experience.  Cindy brings the voice of the parent and patient to FACTMS in hopes of bringing this amazing treatment to more adolescents around the world.

Ms Elkins is currently a Non-Executive Director at Chimeric Therapeutics (ASX:CHM), a Board Trustee at Vitalant and Board Co-Chair of the Foundation for Art and Healing.

She received her BS in Applied Mathematics from UCLA and her MBA from Santa Clara University.